Alan W.Partin M.D., Ph.D., Professor of Urology the Johns Hopkins Medical Institution, has both basic science and clinical interest in prognosis prediction for men with prostate cancer.
Dr. Partin's laboratories and clinical and surgical interest are focused on development and testing of new and existing methods for predicting the aggressiveness of prostate cancers so that rational treatment decisions can be made by both patients and physicians. Dr. Partin's laboratories have investigated many new serum tests, some of which are soon to become available for the diagnosis of prostate cancer as well as basics science investigation of new proteins, which may help in detection, and staging of prostate cancer. In addition, Dr. Partin has an academic and clinical interest in treatment of benign prostatic hyperplasia with an emphasis on minimally invasive techniques for treatment of this common disease of men. Dr. Partin earned his B.A. in chemistry from the University of Mississippi in 1983 and graduating first in his class, he came to Johns Hopkins for his medical training, receiving his Ph.D. degree in 1988 and his M.D. in 1989. He served a surgical internship in 1989, a surgical junior residency in 1990, and his urology residency in 1991, before being named to the faculty as an instructor of urology in 1994. He was promoted to associate professor in 1995 and then to professor of urology in 1999. He is the Bernard L. Schwartz Distinguished Professor of Urologic Oncology. The author of more than 350 scientific papers, he is also editor in chief of the journal Urology, editor of the leading urology textbook, Campbell-Walsh Textbook of Urology, associate editor of Prostate Cancer and Prostatic Diseases, associate editor of Urology Reviews, and serves on the editorial boards of the Journal of Andrology, Urology Research and Treatment, Current Urology Reports, Clinical Prostate Cancer and the British Journal of Urology.